R&D Clinical Trials Round-Up: March and April 2026 March and April offered no shortage of talking points for the clinical trials community.
R&D Medical education: Bridging science and clinical practice Emily Harrison, founder and managing director of Nexus Healthcare Education, explains the critical role medical education plays.
R&D Sponsored The UK life sciences sector at a crossroads: Bold decisions ... We all want the same thing: for the UK to succeed, for our workforces to thrive, and for patients and the NHS to benefit.
R&D Sponsored Beyond weight loss: How obesity trial design is evolving For many years, body weight sat at the centre of obesity drug development.
R&D The changing multiple sclerosis landscape: Earlier diagnosis... Multiple sclerosis (MS) is undergoing a meaningful evolution in how it is understood, diagnosed, and managed.
R&D Navigating the strategic path to enantiopurity A closer look at how controlled crystallisation and complementary approaches can be used to efficiently separate and purify chiral molecules.
News Neurocrine receives FDA IND Acceptance for Alzheimer’s Ph2 Nxera Pharma has announced that partner Neurocrine Biosciences has received IND Acceptance from the FDA a Ph2 of NBI-1117567 in Alzheimer's cognition.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
